Efficacy and safety of nivolumab for metastatic biliary tract cancer

OBJECTIVE: PD-1 inhibitors have improved efficacy in many cancers. There are currently no reports of the use of PD-1 inhibitors, such as nivolumab, for metastatic biliary tract cancer (mBTC). This study reviewed the efficacy and safety of nivolumab for mBTC with the aim of exploring ways to improve...

Descripción completa

Detalles Bibliográficos
Autores principales: Gou, Miaomiao, Zhang, Yong, Si, Haiyan, Dai, Guanghai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355165/
https://www.ncbi.nlm.nih.gov/pubmed/30774373
http://dx.doi.org/10.2147/OTT.S195537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355165/
https://www.ncbi.nlm.nih.gov/pubmed/30774373
http://dx.doi.org/10.2147/OTT.S195537

Ejemplares similares